These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 11899146

  • 1. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
    Nevala H, Karenko L, Vakeva L, Ranki A.
    Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
    [Abstract] [Full Text] [Related]

  • 2. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
    Zoi-Toli O, Vermeer MH, De Vries E, Van Beek P, Meijer CJ, Willemze R.
    Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
    [Abstract] [Full Text] [Related]

  • 3. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A, Nishikawa T.
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [Abstract] [Full Text] [Related]

  • 4. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
    Boulland ML, Wechsler J, Bagot M, Pulford K, Kanavaros P, Gaulard P.
    Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
    [Abstract] [Full Text] [Related]

  • 5. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
    Clarke LE, Bayerl MG, Bruggeman RD, Mauger D, Ioffreda MD, Abou-Elella A, Helm KF.
    Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Primary cutaneous peripheral T-cell lymphoma, not otherwise specified, associated with lymphomatoid papulosis after a 9-year follow up: A case report.
    Muraoka K, Fujimoto M, Iwahashi Y, Matsuzaki I, Yonei N, Murata SI, Jinnin M.
    J Dermatol; 2020 Jun; 47(6):641-645. PubMed ID: 32323371
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells.
    Zhang CL, Kamarashev J, Qin JZ, Burg G, Dummer R, Döbbeling U.
    J Pathol; 2003 Jun; 200(2):249-54. PubMed ID: 12754746
    [Abstract] [Full Text] [Related]

  • 12. Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.
    Ni X, Zhang C, Talpur R, Duvic M.
    J Invest Dermatol; 2005 Apr; 124(4):741-50. PubMed ID: 15816832
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
    Saggini A, Gulia A, Argenyi Z, Fink-Puches R, Lissia A, Magaña M, Requena L, Simonitsch I, Cerroni L.
    Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases.
    Harvell J, Vaseghi M, Natkunam Y, Kohler S, Kim Y.
    J Cutan Pathol; 2002 Feb; 29(2):88-92. PubMed ID: 12150138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.